Healthcare >> CEO Interviews >> July 5, 2004

HOLLINGS RENTON – ONYX PHARMACEUTICALS INC (ONYX)

HOLLINGS C. RENTON was appointed Chairman of the Board of Onyx Pharmaceuticals in June 2000, where he has served as President and Chief Executive Officer since joining the company in March 1993. Prior to Onyx, Mr. Renton was President and Chief Operating Officer of Chiron Corporation. He assumed that position in 1991 on Chiron's acquisition of Cetus Corporation, where he had been President since 1990 and Chief Operating Officer since 1987. He holds an MBA from the University of Michigan. Mr. Renton serves as a member of the board of Cepheid, Rigel Pharmaceuticals, Inc., the Biotechnology Industry Organization (BIO) and Special Olympics Northern California. Profile
TWST: What progress has Onyx made in the past year that investors should

focus on?

Mr. Renton: The last 12 months have probably been one of the most

significant years in our history. During